Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
0.9%
1w
3.7%
1m
0.5%
3m
0.4%
6m
11.0%
1y
13.5%
all
17.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 849 0.9%
740
895
Company Overview
Sales
904 Cr
Growth: 17.9%
Profit after Tax
66.5 Cr
Growth: -0.4%
Small Cap
1,753 Cr
P/E: 27.2x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 904
Growth 17.9%
EBITDA 11.6%
P/S 1.9x
Dividend 0.6%
P/E 27.2x
Book Value ₹ 281
PEG Ratio 1.5x
ROE 12.1%
P/B 3.1x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (3)
jainam.b...
ajay.kum...
ravi036
Followers (2)
kotekar
varsha96